@MarjoNiemenmaa @KahAnssi @HennaFab On mielenkiintoista, että Suomessa Paxlovidia eivät voi saada 80 vuotta täyttäneistä muut kuin osa kotona kotona asuvista. Tämän tutkimusartikkelin mukaan Paxlovid on kuitenkin kustannustehokas hoito Kiinassa vain yli 80
1,707 followers
145 followers
2-27-23: China: In this new study, even at discounted Chinese prices, Paxlovid was not cost-effective: https://t.co/ZKyZoUCP3T In virtually all Paxlovid studies, the better-educated, healthier people volunteered to swallow it, while the unemployed, unheal
5,125 followers
New Research: Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China: Objectives To assess the cost-effectiveness of Paxlovid in reducing severe COVID-19 and its associated morality, and to… #PublicHealth #HealthForAll https://t